文献速递细菌感染、耐药与抗菌药物医院感染防控新发突发、热带与寄生虫病

国家抗微生物耐药行动计划中诊断优先级的评估

Assessment of the Prioritization of Diagnostics in National Action Plans for Antimicrobial Resistance.
PubMed 文献 · Clin Infect Dis · 2026-01-01

该研究对142份WHO成员国国家抗微生物耐药(AMR)行动计划进行定向分析,发现95.8%包含诊断内容,但主要集中于监测和实验室能力建设。床旁诊断(POC)仅出现在33.1%的计划中,且在高收入国家更常见;诊断相关关键绩效指标(KPI)仅见于24.6%的计划,高收入国家尤为缺乏。研究提示需改进战略规划以将AMR目标转化为可交付行动。

要点

  • 多数国家AMR行动计划纳入诊断,但以监测和实验室能力为主。
  • 床旁诊断在低收入和中等收入国家计划中代表性不足。
  • 诊断相关KPI缺乏,尤其在高收入国家,阻碍有效评估。

核心结论

  • 诊断在多数国家AMR行动计划中有所体现,但床旁诊断代表性不足,尤其在中低收入国家。
  • 诊断相关KPI缺乏,尤其在高收入国家,妨碍有效评估。
  • 研究强调需改进战略规划,确保AMR目标转化为可交付行动。

研究设计与样本

  • 对WHO成员国现有国家AMR行动计划进行定向分析。
  • 共分析142份国家行动计划。
  • 使用预定义检索词和分析框架评估诊断模式、关键诊断活动及诊断相关KPI。

主要发现

  • 136/142(95.8%)的计划包含诊断内容,主要在监测(131/142 [92.3%])和实验室能力建设(113/142 [79.6%])背景下。
  • 培养基于诊断出现在124/142(87.3%)的计划中,床旁诊断和实验室分子诊断各出现在47/142(33.1%)的计划中。
  • 床旁诊断在高收入国家计划中频率最高(24/44 [54.5%]),在欧洲区域计划中为21/37(56.8%)。
  • 诊断特异性KPI见于35/142(24.6%)的计划,床旁诊断特异性KPI见于9/142(6.3%)的计划。
  • 诊断KPI在非洲区域计划中频率最高(15/36 [41.7%]),在中低收入国家计划中为13/42(31.0%)。

临床怎么用

  • 感染科医生在参与AMR行动计划制定或评审时,应推动纳入床旁诊断并设置诊断相关KPI。
  • 在资源有限地区,应优先加强床旁诊断的可及性和实验室能力建设。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clinically diagnosing antimicrobial resistance (AMR) remains a challenge, with significant variation in countries' readiness and ability to address it. This study explores how diagnostic capabilities feature in national action plans (NAPs) for AMR, to respond to and manage infections in human health. METHODS: A targeted analysis was conducted of available NAPs of World Health Organization member states. NAPs were analyzed using predefined search terms and an analytical framework for diagnostic modality, key diagnostic activities (laboratory capacity, external quality assessment, surveillance, antimicrobial stewardship, and research) and key performance indicators (KPIs) specific to diagnostics. RESULTS: Of the 142 NAPs analyzed, 136/142 (95.8%) included diagnostics, mostly in the context of surveillance (131/142 [92.3%]) and building laboratory capacity (113/142 [79.6%]). Culture-based diagnostics appeared in 124/142 (87.3%) NAPs, point-of-care (POC) diagnostics in 47/142 (33.1%), and laboratory-based molecular diagnostics in 47/142 (33.1%). POC diagnostics were included most frequently in high-income country (HIC) NAPs (24/44 [54.5%]), and NAPs of the European region (21/37 [56.8%]). Diagnostic-specific KPIs were found in 35/142 (24.6%) NAPs, and KPIs specific to POC diagnostics in 9/142 (6.3%). Diagnostic KPIs were included most frequently in NAPs of the African Region (15/36 [41.7%]) and low- and middle-income countries (13/42 [31.0%]). CONCLUSIONS: While diagnostics feature in most NAPs, POC diagnostics are underrepresented, particularly in low- and middle-income countries lacking diagnostic infrastructure and resources. The lack of KPIs, particularly in HICs, prevents effective evaluation. This study highlights the need for improved strategic planning to ensure NAP objectives are translated into real-world deliverable action to manage AMR.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Lamb G, Pallett SJC, Charani E, et al. Assessment of the Prioritization of Diagnostics in National Action Plans for Antimicrobial Resistance. Clin Infect Dis. 2026. PMID: 42053211. doi:10.1093/cid/ciag020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。